Novonesis A/S

NSIS B

DK0060336014

Specialty Chemicals

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2024-07-12 am EDT			5-day change	1st Jan Change
431 ^DKK	+0.44%		-1.03%	+16.14%

Jun. 18	Transcript : Novozymes A/S - Analyst/Investor Day
Jun. 18	European shares advance ahead of inflation data, more c.bank speakers	RE

Completion of the combination between Novozymes and Chr. Hansen

January 29, 2024 at 05:26 am EST

Please read the full announcement in PDF

Attachment

2024_02_Completion_Of_The_Combination

Latest news about Novonesis A/S

Transcript : Novozymes A/S - Analyst/Investor Day	Jun. 18
European shares advance ahead of inflation data, more c.bank speakers	Jun. 18	RE
NOVONESIS : Key segments outperform in average Q1 24 showing	May. 10
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	May. 03
Novonesis Provides Sales Guidance for the Year 2024	May. 03	CI
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	Apr. 30	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	Apr. 08	CI
China to speed up 'new productive forces', vice president says	Mar. 26	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	Mar. 21	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	Mar. 21
Novonensis expects 2024 adjusted EBITDA margin of 35%	Mar. 21	RE
Novonesis Provides Earnings Guidance for the Year 2024	Mar. 21	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18	CI
FMC Partners With Novonesis in Canada for Biosolution Products	Mar. 12	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	Mar. 07	CI
Novozymes A/S Announces Board Appointments	Mar. 04	CI
Transcript : Novozymes A/S - Shareholder/Analyst Call	Mar. 04
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	Feb. 12	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	Feb. 08
Novozymes, Chr. Hansen Complete Merger Settlement	Feb. 02	MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024	Feb. 01
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	Jan. 29	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	Jan. 28	CI

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).

Sector

Specialty Chemicals

Calendar

2024-08-27 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 12:32 pm EDT

More Strategies

Ratings for Novonesis A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

431 DKK

Average target price

455.6 DKK

Spread / Average Target

+5.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
NOVONESIS A/S	+16.14%	29.27B
CATHAY BIOTECH INC.	-21.81%	3.45B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-20.63%	566M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-30.70%	372M
BIO-ON S.P.A.	-81.65%	216M
CHEMCON SPECIALITY CHEMICALS LIMITED	-9.27%	117M

Industrial Biotechnology Chemicals

Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Completion of the combination between Novozymes and Chr. Hansen

Latest news about Novonesis A/S

Chart Novonesis A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Novonesis A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Industrial Biotechnology Chemicals